Viewing Study NCT02520557


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-05-17 @ 12:43 PM
Study NCT ID: NCT02520557
Status: TERMINATED
Last Update Posted: 2021-01-22
First Post: 2015-08-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine Acetate
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SEP093-452
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View